Britain's health regulator has approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years.
The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got regulatory nod for use in children aged 12 to 15.
Moderna's vaccine was recommended for use in adolescents by European regulators in July and is awaiting US authorisation.
It is currently approved for people over the age of 18 in the UK.
Britain's Joint Committee on Vaccination and Immunisation (JCVI) gave the go-ahead on August 4 for 16 and 17-year-olds to get their first dose of Pfizer's COVID-19 vaccine ahead of schools returning in September.
JCVI will make a decision on whether the vaccine will be deployed or not.
Slow movement at Gaza border after Israel reopens Rafah crossing
Air India checking fuel switches on its Boeing Dreamliners, memo says
Trump seeks $1 billion from Harvard University in damages
US to cut tariffs on India to 18%, India agrees to end Russian oil purchases
Son of Norway's crown princess stands trial for domestic violence
Israel reopens Gaza's Rafah border crossing to Egypt, with limits
US envoy Witkoff to visit Israel, meet Netanyahu, Israeli officials say
Russian drone strike kills 12 miners in Ukraine
